Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE Trial.
Dennis I NarcisseHwasoon KimLisa M WruckAmanda L StebbinsDaniel MuñozSunil KripalaniMark B EffronKamal GuptaR David AndersonSandeep K JainSaket GirotraJeff WhittleCatherine P BenzigerPeter FarrehiLi ZhouTamar S PolonskyFaraz S AhmadMatthew T RoeRussell L RothmanRobert A HarringtonAdrian F HernandezW Schuyler JonesPublished in: Diabetes care (2023)
This study confirms the inherently higher risk of patients with DM irrespective of aspirin dosing. Our findings suggest that a higher dose of aspirin yields no added clinical benefit, even in a more vulnerable population.